Literature DB >> 25054246

Outcome of osseointegrated dental implants in double-barrel and vertically distracted fibula osteoseptocutaneous free flaps for segmental mandibular defect reconstruction.

Yang-Ming Chang1, Christopher Glenn Wallace, Yueh-Min Hsu, Yu-Fu Shen, Chi-Yin Tsai, Fu-Chan Wei.   

Abstract

BACKGROUND: Osseointegrated dental implants in double-barrel, or single-barrel and then vertically distracted, fibula osteoseptocutaneous free flaps can achieve segmental mandibular reconstruction, dental rehabilitation, and premorbid facial height. However, it remains unknown which configuration provides better osseointegration outcomes.
METHODS: Between 2003 and 2009, all patients who underwent segmental mandibular defect reconstruction using vertical distraction osteogenesis of single-barrel fibula with secondary osseointegration (group A, 10 patients and 35 osseointegrated dental implants) or double-barrel fibula with primary osseointegration (group B, 13 patients and 36 osseointegrated dental implants) were evaluated prospectively for crown-implant ratios, mesial/distal marginal bone losses, and complications. In group B, 18 osseointegrated dental implants were surrounded by palatal mucosal grafts; the other retained fibula skin paddles.
RESULTS: Palatal mucosal grafts in group B improved mesial (p<0.001) and distal (p<0.001) marginal bone losses. Mesial marginal bone loss of group B with palatal mucosal grafts was better than that of group A (p<0.05), despite higher crown-implant ratios in group A (p<0.01). Mesial (p<0.01) and distal (p<0.05) marginal bone losses of group A were better than that of group B osseointegrated dental implants without palatal mucosal grafts. Complications in group A were common and complex, unlike group B. All patients completed dental rehabilitation.
CONCLUSIONS: Osseointegration was adequate to complete dental rehabilitation in group B without palatal mucosal grafts, but was significantly better in group A, and significantly best in group B with palatal mucosal grafts. Given the complexity and frequency of complications in group A, the authors recommend the double-barrel configuration with osseointegrated dental implants for segmental mandibular defect reconstruction. Palatal mucosal grafts have a definite advantage. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

Entities:  

Mesh:

Year:  2014        PMID: 25054246     DOI: 10.1097/PRS.0000000000000623

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  6 in total

1.  The role of folded fibular flap in patients' reconstruction of mandibular defects: a retrospective clinical study.

Authors:  Ning Gao; Kun Fu; Jinghua Cai; Hao Chen; Wei He
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

Review 2.  What Is the Success of Implants Placed in Fibula Flap? A Systematic Review and Meta-Analysis.

Authors:  Pooja Gangwani; Mohammed Almana; Basir Barmak; Antonia Kolokythas
Journal:  J Oral Maxillofac Res       Date:  2022-03-31

3.  [Clinical application and accuracy analysis of occlusion-guided functional mandibular reconstruction].

Authors:  Dan Yu; Jianyao Huang; Changyang Yu; Junling Chen; Wenquan Zhao; Jianhua Liu; Huiyong Zhu
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-11-15

Review 4.  Mandibular Reconstruction Using the Free Vascularized Fibula Graft: An Overview of Different Modifications.

Authors:  George Kokosis; Robin Schmitz; David B Powers; Detlev Erdmann
Journal:  Arch Plast Surg       Date:  2016-01-15

5.  Bilateral Distraction Osteogenesis of Vascularized Iliac Crest Free Flaps Used in Mandibular Reconstruction.

Authors:  Alexander M Bobinskas; Shiva S Subramaniam; Nathan J Vujcich; Alf L Nastri
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-03-08

6.  Analysis of Fibular Single Graft and Fibular Double-barrel Graft for Mandibular Reconstruction.

Authors:  Naohiro Ishii; Yusuke Shimizu; Jyun Ihara; Kazuo Kishi
Journal:  Plast Reconstr Surg Glob Open       Date:  2016-08-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.